Return on Equity (ROE) score
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity. Higher ROE indicates better management effectiveness at converting investments into earnings.
How StocksScores scores it
ROE, in percent, is scored on the sector return-on-equity band. Scored against a sector band where higher is better: a value at the band's floor scores about 35, at its ceiling about 95, linear in between; half a band-width below the floor scores about 5, and beyond either end the score keeps easing toward 0 or 100 instead of clipping. The band is picked by industry first (consumer electronics, semiconductors, grocery and discount retail have their own), then by sector, else a general default. Example with the default band (10% to 20%): 10% scores about 35, 15% about 65, 20% about 95, 0% about 3; the Technology band is 15% to 60%. Because the primary source is the annual statement, the figure can lag a company whose earnings are changing fast.
Data: Net income divided by shareholders' equity from the latest Finnhub annual statements; if that cannot be computed (missing data or equity not positive), Yahoo Finance returnOnEquity.
Not scored when: Neither the Finnhub calculation nor Yahoo provides a value.
Weight in the stock score
It carries 4% of the fundamental pillar's weight (3 of 84). The fundamental total is then ranked within the company's sector, and that pillar is 80% of the composite score.
The full method — timeframes, the sector ranking and how missing data is handled — is on how the stock score works. For the metric itself, read Financial Ratios Cheat Sheet: 15 Key Metrics for Investors.
Return on Equity (ROE) across US stocks today
2,273 US companies worth $1B or more have a Return on Equity (ROE) reading as of Nov 19, 2026; the median scores 40.
- Bearish · 0–39
- 1,117
- Weak · 40–49
- 261
- Neutral · 50–65
- 292
- Bullish · 66–79
- 162
- Very bullish · 80–100
- 441
Median by sector
| Sector | Stocks | Median |
|---|---|---|
| Energy | 149 | 65 |
| Financial Services | 414 | 49 |
| Utilities | 78 | 44 |
| Consumer Cyclical | 226 | 43 |
| Industrials | 306 | 43 |
| Consumer Defensive | 99 | 42 |
| Real Estate | 116 | 37 |
| Technology | 344 | 32 |
| Communication Services | 99 | 31 |
| Basic Materials | 126 | 31 |
| Healthcare | 316 | 3 |
Highest Return on Equity (ROE) scores
| Company | Sector | Market cap | Score |
|---|---|---|---|
| AAPL Apple | Technology | $5.07T | 100 |
| LLY Eli Lilly and Company | Healthcare | $1.20T | 100 |
| V Visa | Financial Services | $750.5B | 100 |
| MA Mastercard | Financial Services | $545.8B | 100 |
| HD The Home Depot | Consumer Cyclical | $335.9B | 100 |
| AMGN Amgen | Healthcare | $237.4B | 100 |
| NVO Novo Nordisk A/S | Healthcare | $171.3B | 100 |
| LMT Lockheed Martin | Industrials | $132.1B | 100 |
| APP AppLovin | Communication Services | $125.6B | 100 |
| STX Seagate Technology Holdings | Technology | $119.7B | 100 |
| WDC Western Digital | Technology | $111.1B | 100 |
| FTNT Fortinet | Technology | $96.6B | 100 |
| MMM 3M Company | Industrials | $92.2B | 100 |
| SPG Simon Property Group | Real Estate | $85.3B | 100 |
| AMT American Tower | Real Estate | $84.0B | 100 |
| SHW The Sherwin-Williams Company | Basic Materials | $82.1B | 100 |
| MCO Moody's | Financial Services | $81.4B | 100 |
| ITW Illinois Tool Works | Industrials | $78.7B | 100 |
| CL Colgate-Palmolive Company | Consumer Defensive | $77.0B | 100 |
| RELX RELX | Industrials | $67.3B | 100 |
Lowest Return on Equity (ROE) scores
| Company | Sector | Market cap | Score |
|---|---|---|---|
| CBLL CeriBell | Healthcare | $1.0B | 0 |
| KOS Kosmos Energy | Energy | $1.0B | 0 |
| HBNC Horizon Bancorp | Financial Services | $1.0B | 0 |
| GT The Goodyear Tire & Rubber Company | Consumer Cyclical | $1.0B | 0 |
| JBIO Jade Biosciences | Healthcare | $1.0B | 0 |
| DRTS Alpha Tau Medical | Healthcare | $1.0B | 0 |
| IART Integra LifeSciences Holdings | Healthcare | $1.1B | 0 |
| ATEC Alphatec | Healthcare | $1.1B | 0 |
| SBGI Sinclair | Communication Services | $1.1B | 0 |
| ANRO Alto Neuroscience | Healthcare | $1.1B | 0 |
One scorer is one input among many, not a recommendation. Each company’s page shows every scorer behind its composite.